SUMMARY In a large family with the fragile X syndrome, we performed linkage investigations with six probes, detecting RFLPs at both sides of the fragile site Xq27. The nearest flanking markers were cX55-7 (DXS105) on the centromeric side (0=0-04, lod 5-0) and Stl4 (DXS52) on the telomeric side (0=0-08, lod 4.0).
Since the detection of the fragile site Xq27, the fragile X syndrome has increasingly confused genetic counsellors and cytogeneticists. According to Sherman et al,l no more than 56% of female carriers show cytogenetic or clinical expression and approximately 20% of affected males are missing from the expected segregation rate. These non-penetrant males, however, are able to transmit the abnormality to their daughters. Clearly, diagnostic techniques other than the conventional methods are needed to improve the detection of the abnormality.
The application of cloned genomic DNA probes, detecting restriction fragment length polymorphisms (RFLPs), has already proven to be of great diagnostic value in a number of genetic diseases in which the primary biochemical defect is still unknown. Particularly in X linked recessive diseases, like haemophilia and Duchenne muscular dystrophy, it has facilitated carrier detection and has even To obtain as many informative meioses as possible, 76 family members were asked to participate. All had been investigated cytogeneticallyl' except for IV.6 who initially refused but later consented to giving some blood. He is a normal man who finished primrary and secondary school and ran his own business in horticulture. No fragile site Xq27 was found in 100 lymphocytes from his peripheral blood. The numbers in the pedigree (fig 1) indicate the 67 subjects who agreed to take part in this study. Lod scores were calculated at intervals of a genetic distance of 5 cM (0=0-05). The linkage data on this family (excluding IV.52 and her daughters, who strictly speaking belong to a second fra(X) family) between the six DNA markers and the fra(X) are presented in table 3. Mutual linkage between the markers has also been analysed. The maximum lod scores and 95% confidence limits of various thetas are given in table 4.
No positive lod scores between the fra(X) and 52A (DXS5J) were found at any distance. A peak lod score of 1-9 was found for linkage between fra(X) and the factor IX probe, with a recombination frequency of 16%. A peak lod score of 5-0 was calculated for linkage with cX55-7 (DXSJ05) at 0=0 04. This marker is not only closely linked to the fragile site but also to factor IX (0=0.08, lod 3-9). It appears to be located between these two loci on the proximal side of the fragile site. The probability of 416 H Veenema, NJ Carpenter, E Bakker, M H Hofker, A Millington Ward, and The nearest markers on the telomeric side are Discussion Stl4 (DXS52) at 0=0*08 (lod score 4-0), followed by DX13 (DXSJ5) at 0=0*19 (lod 1-7), and finally by The development of the probe cX55*7 detecting a pX67, which appeared to be closely linked with DNA polymorphism between factor IX and the DX13 at 0=0-08, lod 5.5.
Xq27 fragile site4 not only serves a diagnostic purpose, but may also increase our understanding of Order is cX55-7-factor IX-fra(X). Recombination distance is fixed at 0=0-08 for cX55-7 to factor IX and is allowed to vary between factor IX and fra(X). Order is factor IX-cX55.7-fra(X).
Recombination distance is fixed at 0=0-08 for cX55-7 to factor IX and is allowed to vary between cX55-7 and fra(X). Intermediate between the two non-penetrant males and the fully penetrant male patients is the non-retarded man (IV. 10), who expressed the fra(X) in 6/100 of his cells. Such quantitative differences in penetrance could fit with the hypothesis of Nussbaum et a129 which postulates that expression rates depend on the extent of the amplification of pyrimidine rich DNA sequences. It implies that repair mechanisms may cause the disappearance of the abnormality, resulting in nonpenetrance, as in V.76. Partial penetrance, as in IV.10, could then be explained by partial repair.
This would fit in with the theory of Pembrey et a130 that a stepwise progression of a genetic change, probably resulting from duplication or deletion, generates the fra(X) mutation. The mechanism for such a process may be found in misalignment and repair might simply mean a deletion of the amplified sequences.
Yet another non-retarded male in this family (V.68), whose mother was only informative for DX13 and cpX67, showed the fragile site in 1/100 cells. However, he seems to have inherited the normal X chromosome, which throws doubt upon the diagnostic meaning of the cytogenetic result. From these data we conclude that the choice of a low cut off point (2%) to evaluate the cytogenetic results is of little clinical value; moreover, this value takes no account of false negatives. It also appears that without closely linked markers it is almost impossible to distinguish between penetrant and nonpenetrant fra(X) families. Non-penetrance will remain unnoticed unless the family history indicates otherwise. In the case of V.76 no indication for nonpenetrance, other than the RFLP data, was present.
We have already mentioned the data indicating a rather loose linkage between 52A (DXS5) and the fragile site. Pembrey et aP30 have drawn attention to the fact that transmission through a female carrier seems to be necessary to generate the fully penetrant form of the fra(X) mutation. In a recent paper, Winter and Pembrey 3 suggested that support for their theory of (double) recombination or gene conversion within the fra(X) region being necessary for the difference between penetrant and non-penetrant expression could be found by examining recombination frequencies in adjacent sequences. Classic meiotic theory would predict that occurrence of recombination within one segment would probably lead to suppression of recombination in neighbouring sequences by interfering. In the fra(X) concept proposed by Winter and Pembrey33 this would result in lower recombination frequencies in adjacent sequences in the same meiosis giving rise to penetrant males.
We studied the data on 12 children, born to four daughters of 111.12: six males and six females. Three males expressed the fragile site and were mentally retarded: non-penetrance had changed into full cytogenetic and clinical penetrance (V.57, 63, 67).
Three of the females were also mentally retarded (V.56, 59, 62). They expressed the fragile site in considerably larger percentages than two nonretarded carriers (V.54, 55). One woman was normal (V.60). In the six retarded subjects, one crossover had occurred in the region of the fragile site itself (V.62) and one crossover outside the region between 52A and factor IX (V.56), whereas in the six subjects without a change in penetrance (the normal woman included), seven meiotic recombinations could be demonstrated. Although these numbers are too small to draw conclusions, the ratio one or two to seven seems compatible with the hypothesis mentioned above.
For scientific and clinical reasons the promising investigations with recombination DNA methods must be continued actively, to solve the numerous questions about the fragile X syndrome.
